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Abstract 
While assessing the performances of companies, the decision makers to take not only a single criterion 
for making the right decisions in to account, but also a number of other relevant criteria that could 
affect the performance. Because when it is necessary to make the best selection among several option, 
Multiple-Criteria Decision Making (MCDM) methods are used. This study is to provide insight in to the 
applicability of method Simple Additive Weightings Method (SAW) and Additive Ratio Assessment 
(ARAS) method under MCDM techniques to evaluate the performance of Indian Pharmaceutical 
companies during the study period 2006-2019. The seventeen evaluation criteria’s were used in the 
application. The constructed model was analysed using both SAW and ARAS method. The study results 
showed that the best performance belongs to Glico Smith Kline Pharma Limited in SAW method and 
Sun Pharmaceutical Industries Ltd in ARAS method and worst performance belongs to Ranbaxy 
Laboratories Limited in both methods. By comparison, both methods revealed the similar rankings of 
companies during the study period. 
Keywords 
financial performance, mcdm, saw method, aras method, Indian pharmaceutical companies, entropy 
method, financial soundness and firm’s performance 
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1. Introduction 
The Indian industrial sector has undergone regulatory changes as the consequences of the economic 
reforms between 1988 and 1991. India moved away from ’control’ era towards the “open” economy 
model. It should bring out a dramatic change in Indian Pharmaceutical companies. Firm’s performance 
is dependent on both financial and non-financial conditions of the firm. For this purpose, profitability, 
assets utilization, liquidity, working capital efficiency, long-term solvency, market value and foreign 
trade measures are grouped under financial indicators and other indicators such as sales and marketing 
strategy, consumer satisfaction, technological issues, human resources and growth variables are 
grouped under non-financial indicators. However, in this study, an attempt has been made to analyse 
the financial indicators only which help to measure the financial performance of selected Indian 
Pharmaceutical companies. 
In many real world decision problems, a decision maker has set of multiple conflicting objectives. The 
decision must be compared according to many criteria (Turskis et al., 2009). The problem of a decision 
maker is to evaluate a finite set of alternatives in order to find the best one, to rank them from the best 
to worst or to describe how well each alternative meets all the criteria simultaneously (Zavadskas & 
Turskis, 2010). There are many methods of determining the ranking of a set of alternatives in terms of a 
set of decision criteria. In a multicriteria approach, the researchers to build several criteria using several 
views. Multi-Criteria Decision-Making(MCDM) is one of the most widely used decision methodology 
used in science, business and government and help to improve the quality of decisions by making the 
decision making process more efficient. The MCDM represents one of the fastest growing fields of 
operation research. It has over the time bound its application in solving various decision making 
problems. 
 
2. Method 
2.1 Indian Pharmaceutical Industry—Sectorial Background 
In the year 1969, Indian pharmaceuticals had a 5 per cent share of the market in India and global 
pharma had a 95 per cent share. By 2020, Indian pharma having an almost 85 per cent share and global, 
15 per cent. Over the last 50 years, Indian pharmaceutical companies have been successful in meeting 
the domestic needs as well as building a leading position in the global landscape. The pharmaceutical 
industry in India is worth about $37 billion, with exports accounting for about $18 billion. Indian 
pharma now ranks 3rd worldwide in volume and 13 in value. The growth rate of the industry is 13 per 
cent per year. Almost 70 per cent of the domestic demand for bulk drugs is catered by the Indian 
pharma industry. The Indian pharma industry produces around 20 per cent to 25 per cent of the global 
generic drugs. It is one of the biggest producers of the Active Pharmaceutical ingredients (API) in the 
international arena. Around 40 per cent of the total pharmaceutical produce is exported. The Indian 
pharma industry includes small, medium and large scaled players around 300 different companies. 
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India is a leading exporter of generic drugs across the globe and as demand expands across the globe, 
Indian pharmaceutical industry aspires to become the world’s largest supplier of drugs by 2030. 
Indian pharmaceutical companies played an important role in the global fight against the coronavirus 
pandemic that had affected over 3 million people across the world. Hydroxychloroquine has been 
identified by the US Food and Drug Administration as a possible treatment for the Covid-19. India, one 
of the largest producers of anti-malarial drug Hydroxychloroquine, has seen spurt in demand in recent 
weeks. India has sent the drug to over 50 countries over the last few weeks including United States. 
However, in the last couple of years, Indian pharma industry has faced several challenges such as 
higher level of customer consolidation, increased competition and number of product approvals, 
increased pricing control, transient impact of demonetisation and continued to face destructions from 
regulatory bodies. Further, our strong position as a global supplier of high quality and affordable 
medicines has also been impacted due to recent compliance challenges and low productivities. The 
profits are under severe pressure. Hence, the continued viability of Indian pharma industry is of 
strategic concern for the government, industry and stakeholders. 
2.2 Justification for the Study 
Financial performance of firms is subject to continuous monitoring. Good financial conditions leads to 
growth and development and guarantee satisfaction to all stakeholders. On the other hand poor 
performance may lead to negative consequences for the achievement of goals of all the stakeholders 
involved. An evaluation of financial performance is a multidimensional assessment based on multiple 
criteria including profitability, asset utilisation, liquidity, working capital efficiency, solvency and 
market value measures. For this reason, developing a ranking of entities so as to make comparisons 
among them by using Multiple Criteria Decision Making (MCDM). While taking a decision, there 
might be many alternatives with distinct criterions. The MCDM is an approach designed for the 
evaluation of problems with a finite or an infinite number of choices. 
2.3 MCDM Methodology 
The Multiple Criteria Decision Making is defined as the process of selecting one from set of available 
alternatives or ranking alternatives based on a set of criteria. The MCDM methods transform multiple 
criteria optimization in a single criterion decision-making optimization, which is much easier to solve. 
There are different phases in MCDM process which includes criteria weight determination, 
normalization, aggregation and selection. A typical MCDM problem can be presented in the following 
form. 
                  D = [xij] mxn                                                             ….. (1) 
                       W = [wj] n                                                               ….. (2) 
Where D is decision matrix, xijis performance of ith alternative with respect to jthcriterion, w is the 
weight vector, wj is weight of jth criterion, i=1, 2, …..m; m is the number of compared alternatives, 
j=1,2, …..n; n is the number of criteria.  
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Information stored in a decision matrix expressed using different units of measure. Therefore, data 
should be transformed in to comparable values, using a normalization procedure. For normalization 
numerous procedures were given by Zavadskas and Turskis (2008). Evaluation criteria involved in the 
MCDM models can be classified in to two types namely; benefit criteria, i.e., the higher rating is better; 
and cost criteria, i.e., the lower rating is better. In MCDM, evaluation criteria usually have different 
importance (weights), and it is also important that weights of criteria often have a large impact on 
selection of the most acceptable alternative. 
2.4 Literature Reviews 
Several studies on financial performance evaluation are focussed on ranking the alternatives according 
to their financial performance measures included in their comparison environments. A number of 
research studies have approached various MCDM methods such as SAW, ARAS, COPRAS, MOORA, 
MULTIMOORA, TOPSIS AHP, PROMETHEE and so on. The comparison of above methods is given 
by Turskis and Zavadskas (2011), Stanujkic et al. (2013), Zavadskas et al. (2014) and Mardani et al. 
(2015). However in this study the SAW and ARAS method is chosen because of its simplicity 
compared to other MCDM methods for comparison with respect to Indian Pharmaceutical companies. 
Raikar Avinash (2019) used SAW method to analyse financial performance of the selected 24 steel 
manufacturing firms in India over a period 2014 to 2018. The study uses 17 ratios that broadly cover 
profitability, solvency, stability, managerial efficiency and liquidity. These ratios are the criteria on 
which steel companies are evaluated by using three MCDM techniques ARAS, SAW and TOPSIS. 
Stanujkic et al. (2013) used SAW method in the case of ranking Serbian banks. Dedania et al. (2015) 
used SAW method to evaluate portfolio management for stock ranking. Zolfani et al. (2012) made an 
attempt to evaluate the rural ICT centres by applying Fuzzy AHP, SAW and Gand TOPSIS method. 
Zavadskas et al. (2010) evaluate contractor selection for construction works by applying SAW method 
of MCDM. Chen (2012) made an attempt for comparison of SAW and TOPSIS based on 
interval-valued Fuzzy sets. 
The ARAS method applied to the selection of the chief accountant (Kersuliene & Turkskis 2014), 
measuring the quality of faculty website (Stanujkic & Jovanovic, 2012), the analysis of fuzzy multiple 
criteria in order to select the logistic centers location (Turskis et al. 2010b) multi criteria analysis of 
foundation instalment alternatives (Zavadskas et al., 2010), decision making problems with 
interval-valued Triangular Fuzzy numbers (Stanujkic, 2015), evaluation of microclimate in office 
rooms (Zavadskas & Turskis, 2010), ranking of factoring companies (Asir & Emel, 2017), ranking of 
Serbian Banks (Dragisa et al., 2013), financial performance of steel companies (Raikar, 2019), for 
determining inside climate of the premises (Zavadskas & Turskis, 2010), evaluating quality of air 
transport services (Bakir & Atalik, 2018), personnel selection (Karabasevic et al, 2015), selecting and 
ranking of the vendors (Chatterjee & Bose, 2013), evaluation of mobile banking services (Ecer, 2018), 
identify the indicators of corporate social responsibilities (Karabasevic et al., 2016), the status of 
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building (Kutut et al., 2013), selection of chief accountant (Kersuliene & Turskis, 2013), selection of 
construction project manager assessment (Zavadskas et al., 2012), comparison of different design of 
building (Saparauskas et al., 2011) and so on. 
In literature, various types of MCDM techniques like SAW, ARAS, TOPSIS, VIKOR, GRA, 
ELECTREE, MOORA and PROMETHEE are used to assess the performance of manufacturing 
companies by using ratios derived from the information contained in the financial statement. With such 
an approach one of the simplest and widely used MCDM method for evaluation and ranking of 
alternative is Simple Additive Weighting (SAW) and Additive Ratio Assessment (ARAS) methods. 
Hence, in this study an attempt has been made to ranking selected Indian Pharmaceutical companies by 
using SAW and ARAS method. 
2.5 Simple Additive Weighting (SAW) Method 
Simple Additive Weighting (SAW) Method probably the simplest, best known and formerly often used 
MCDM method (Dragisa, 2013). The SAW method uses a simple aggregation procedure, which is 
presented using the following formula: 
 
                                                                        …… (3) 
where Qi is the overall ranking index of ith alternative; wj is the weight of jjth Criterion, rij is normalised 
the performance of ith alternative with respect of jth criterion, i=1, 2, …..m; and j=1,2, …..n.  
In SAW method, the alternatives are ranked on the basis of their Qi in ascending order, and the 
alternative with the highest value of Qi is the best ranked. The best ranked, or the most preferable, 
alternative, based on the SAW method, can be determined using the following formula: 
 
                                                                        …… (4) 
The method involves three steps: 
Step 1: Construct the decision matrix with m alternative and n criterion as follows  
 
Where xij represents performance of ith alternative on the jth criteria; i=1,2, ....m and j=1,2, .....n 
Step 2: Since the Criteria have different scales, a normalisation process is performed in order to make 
an evaluation. The normalised decision matrix R= [rij] mxn should constructed. Some of typical 
normalisation procedures used in the SAW method are given below. 
(a) Linear Scale Transformation—Max Method: 
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(b) Linear Scale Transformation—Sum Method: 
 
(c) Vector Normalisation: 
 
(d) Linear Scale Transformation—Max Min Method: 
 
Where is the largest performance ratings and is the smallest performance rating of jth criterion, 
 max and  min are sets of benefit and cost criteria, respectively. 
Step 3: Calculate relative importance of the ith alternative based on Simple Attitude Weighting Method 
as shown below. 
 
2.6 Additive Ratio Assessment (ARAS) Method 
ARAS method is a new MCDM procedure which is asserted by Zavadskas and Turskis (Zavadskas & 
Turskis, 2010). The typical MCDM problem is concerned with the task of ranking a finite number of 
decision alternatives, each of which is explicitly described in terms of different decision criteria which 
have to be taken into account simultaneously. According to ARAS method, a utility function value 
determining the complex relative efficiency of a feasible alternative is directly proportional to the 
relative effect of values and weights of the main criteria considered in a project (Edumundas, 
Kazimieras, Zavadskas, & Turskis, 2010). 
In this method, the most acceptable alternative is determined on the basis of degree of utility Qi, which 
can be calculated using the following formula 
            Qi =                                   ….. (5) 
Where Si is overall performance index of ith alternative, So is overall performance index of optimal 
alternative, and So usually has a value which is 1. The alternatives are ranked on the basis their Qi in 
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ascending order, and the alternative with the highest value of Qi is the best ranked. The best ranked 
alternative, based on the ARAS method,  can be determined using the following formula. 
 
The specificity of ARAS method, compared to other methods, is the introduction of the optimal 
alternative . The performances of the optimal alternative are determined on the basis of decision 
maker’s preferences. If the decision makers has no preference about some criterion, its optimal 
performance is determined as follows 
 
The stages of ARAS Method can be put and in an order as follows. 
Step 1: Decision-Making Matrix (DMM) 
Construct the decision matrix with “m” alternative and “n” criteria as follows. 
 
Where A1, A2,.....Am are available alternatives, C1, C2.....Cn  are criteria, Xij is performance rating of i-th  
alternative with respect to jth eth criterion, i= 1,2, ...m and j= 1,2, ...n. 
Step 2: Determine optimal performance rating for each criterion 
After creating a decision matrix, the next step in the ARAS method is to determine the optimal 
performance rating for each criterion.  If the decision marks do not have preferences, the optimal 
performance ratings are calculated as 
 
Where is optimal performance rating in relation to the jth criterion,  max denote a set of benefit 
type criteria, i.e., optimisation direction is maximization: and  min denote a set of cost type criteria, 
i.e., optimisation direction is minimization. 
Step 3: Calculate the normalised decision matrix: 
The third step is to calculate normalised decision matrix R=rij in such that. 
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Where rij is the normalised performance rating of the ith alternative on jth criteria. 
Step 4:  Calculated the weighted normalised decision matrix. 
The weighted normalised performance ratings [V = {Vij}] as calculated as follows:  
 
Where vij is weighted normalised performance rating of ith alternative in the relation to jth criterion. 
Step 5: Calculate the overall performance index for each alternative: 
The overall performance index Si, for each alternative can be calculated as the sum of weighted 
normalised performance ratings, using the following formula. 
                              ….. (6) 
Step 6: Calculate the degree of utility for each alternative. 
In the case of evaluating the alternatives, the degree of utility for each alternatives can be calculated 
using the following formula. 
                                Qi =                
 Where Q1 is degree of utility of ith alternative, and So is overall performance index of optimal 
alternative, and it is usually 1. The largest value of Qi is the best and the smallest one is the worst. 
2.7 Weighting by Entropy Method 
Entropy has become an important concept in the social sciences as well as the physical Sciences 
(Capocelli & De Luca, 1973). In information theory, entropy is a criterion for the amount of uncertainty 
presented by the discrete probability distribution Pi (Jaynes, 1957). Entropy is one of the most widely 
used objective waiting methods. If the data of the decision matrix is available then, the entropy method 
can be very useful to evaluate the weighting (Deng et al., 2000). The entropy concept was defined as a 
measure of uncertainty by Shannon (1948). This measure of uncertainty is given by Shannon (1948) 
with the following equation: 
 
                                                                     …… (7) 
where K is a constant coefficient. Since the entropy expression is first found in statistical mechanics, it 
is called entropy of Pi probability distribution. When all Pi values take Pi=  and S has the greatest 
uncertainty. 
Entropy can be used as the tool for evaluating criteria (Zeleney, 1974; Nijkamp, 1977) if given a 
decision matrix containing information for a certain amount of alternatives. The basic idea of entropy is 
particularly useful when examining the contrast between datasets. If the criterion very similar values to 
its alternatives, then this is the little performance. Even if all the alternatives have the same values, the 
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criterion is ignored. The entropy method measures the uncertainty in the data set and measures the 
variance of the data set with this uncertainty value. For each criterion, the value of the variation value 
in the total variance gives the weight value of the criterion. The decision matrix for a MCDM problem 
comprises a definite quantity of information; entropy can be utilised as an implement in criteria 
evaluation. 
The process of determining the weighted value for the criteria by the entropy method is summarised as 
follows: 
Let mxn-dimensional decision matrix of a decision-making problem with m alternatives and n criteria 
be given as follows: 
 
Where, Xij is the success value of ith alternative, in the jth criterion, i= 1, 2, ....., m; j=1, 2, ......n. The 
values in row Ai indicate success values according to the all criteria of the ith alternative, and the values 
in column xj indicate the success values of all the alternatives according to the jth criterion. 
Step 1: Since the criteria have different scales, a normalisation process is performed in order to make 
and evaluation. R = [rij] mxn normalised decision matrix calculated by the following formula. 
 
The aim of normalisation is to obtain same scale for all criteria and so to make comparison between 
them. (Caliskan, 2013). 
Step 2: The uncertainty measures for each criterion, entropy value, is found by the following equation: 
 
Where K =   is a constant coefficient and 0 ≤ ej ≤ 1 are guaranteed. The value of ej is the 
uncertainty measure of the jth criterion or in other words, the entropy value.  
Step 3: The degree of diversification dj for each criterion using the entropy value of the average 
information contained by the outcomes of criterion j can be obtained as  
 
Step 4: Finally, the weight values of the criteria are calculated by proportioning the degree of 
diversification of each criterion to the sum of the degree of diversification:  
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as addition  is clear. 
2.8 Sample Selection 
The pharmaceutical industry has been chosen for this study because it is one of the important and 
fastest growing sectors in the Indian economy. Among 258 pharmaceutical companies in India, the 
selection of sample companies is based on the following criteria; companies which are listed in BSE; 
companies which provide financial data for the study period of 13 years and companies which have a 
market capitalisation above Rs.15,000 crores. On the basis of the above criteria ten companies listed on 
BSE are used as alternatives or Decision-Making Units (DMU) that includes leading pharmaceutical 
manufacturers operating in Indian pharmaceutical industry. The list of companies considered in the 
analysis is given in the Table 1 along with DMU number. 
 
Table 1. List of Companies used in Financial Analysis 
Number of Decision Making Units (DMU) Name of the Pharmaceutical Company 
DMU-1 Aurobindo Pharma Limited 
DMU2 Cadila Pharmaceutical Limited 
DMU3 Cipla Ltd 
DMU4 Dr. Reddy’s Laboratories Ltd 
DMU5 Glaxo Smith Kline Pharma Ltd 
DMU6 Glenmark Pharmaceuticals Limited 
DMU7 Lupin Ltd 
DMU8 Ranbaxy Laboratories Limited 
DMU9 Sun Pharmaceutical Industries Ltd 
DMU10 Torrent Pharmaceuticals Limited 
 
2.9 Period of Study and Sources of Data 
The competitiveness among Indian pharmaceutical companies is made for a period of thirteen years 
2006-2007 to 2018-2019. The thirteen years period is chosen in order to have a fairly, long cyclically 
well balanced, for which reasonably homogeneous, reliable and up to date financial data would be 
available. The major source of data analysed and interpreted in this study related to all those companies 
selected is collected from “PROWESS” database, which is the most reliable on the empowered 
corporate database of Centre for Monitoring Indian Economy (CMIE). 
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3. Results 
In this section, in order to perform objective conclusions in terms of the applicability of SAW and 
ARAS methods, the influence which the weights of criteria, the used approaches and the applied 
normalization procedure have on the selection of the most appropriate alternative and obtained ranking 
orders of alternatives is taken in to consideration. This study presents the ranking results of selected 
Indian pharmaceutical companies based on objective criteria. These criteria and their sub-criteria 
adopted in this study are shown in Table 2. The financial ratios used in the study were selected from 
those which could provide information about earning capacity, utilization of resources, financial 
soundness and paying ability, debt coverage, management efficiency and investment valuation figures 
of the company. 
 
Table 2. Ratios or Criterion Used in the Analysis along with the Type and Weights of Criterion 
Sl.No. Criteria/Ratio Sub-Criteria Objective 
Weights* 
Type of 
Criterion 
1 Earning Capacity Operating Margin Ratio(OP) 0.007 + 
 Net Profit Margin Ratio(NP) 0.018 + 
2 Utilization of 
Resources 
Return on Capital 
Employed(ROC) 
0.014 + 
Return on Net worth(RON) 0.027 + 
3 Financial Soundness 
and Paying Ability 
Current Ratio(CR) 0.011 + 
Quick  Ratio(QR) 0.015 + 
Debt-Equity ratio(DER) 0.046 - 
4 Debt Coverage Interest Cover(IC) 0.263 + 
5 Management 
Efficiency 
Inventory Turnover(IT) 0.004 + 
Receivables Turnover(RT) 0.063 + 
Fixed Assets Turnover(FT) 0.039 + 
Total Asset Turnover(TAT) 0.005 + 
Cash Conversion Cycle(CCC) 0.006 - 
6 Investment Valuation Earnings Per Share(EPS) 0.369 + 
Price Earnings Ratio(PE) 0.034 + 
Book-Value per Share(BV) 0.023 + 
Dividend Yield(DY) 0.055 + 
+ indicates Benefit Criteria and – Cost Criteria 
* Objective weights are determined based on Entropy Method 
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3.1 SAW Method 
The Indian pharmaceutical companies that have decision points, the superiority of which has to be 
determined through the constituted decision matrix lines, while in the columns, occur in the financial 
performance ratios which are the evaluation criteria’s. Ten decision making units (alternatives) and 17 
evaluation criteria’s were used in the research. First, the standard decision matrix was set with 
dimensions (10x17) for the SAW method obtained from Indian pharmaceutical companies. The 
decision matrix related to the Indian pharmaceutical companies is presented in Table 3. 
 
Table 3. Initial Decision Matrix (SAW Method) 
Companies OP NP ROC RON CR QR DER IC IT 
DMU1 17.4 9.08 13.9 15.1 1.19 2.53 1.14 9.43 4.35 
DMU2 15.5 15.5 19.5 22.7 1.14 1.20 0.56 10.9 5.87 
DMU3 22.7 17.1 23.2 20.6 2.17 1.56 0.12 74.9 3.49 
DMU4 24.2 17.5 17.8 13.4 2.33 2.49 0.15 172.1 6.13 
DMU5 33.3 23.5 45.2 33.7 1.97 1.50 0.31 0.00 6.99 
DMU6 23.2 16.3 16.1 18.9 1.88 3.43 0.86 6.57 6.91 
DMU7 21.1 14.2 23.5 26.8 1.22 1.73 0.77 27.8 5.48 
DMU8 12.1 2.81 12.5 -1.6 1.12 1.04 1.40 18.9 4.31 
DMU9 16.3 25.5 21.8 19.5 2.94 2.63 0.32 924.1 5.46 
DMU10 21.9 14.7 24.6 24.1 1.51 1.13 0.41 27.6 5.13 
Companies RT FT TAT CCC EPS PE BV DY 
DMU1 3.00 2.38 0.86 184.7 31.8 2.24 175 0.01 
DMU2 6.76 1.91 1.07 145.7 24.3 4.69 106 0.05 
DMU3 4.40 2.70 1.08 231.4 20.7 5.16 98 0.04 
DMU4 3.70 2.73 0.77 164.8 50.8 8.67 325 0.02 
DMU5 26.4 10.9 1.39 95.3 53.3 33.5 173 0.18 
DMU6 3.27 3.53 0.76 212.9 10.3 6.19 60 0.02 
DMU7 4.27 2.37 1.17 161.7 36.1 3.92 132 0.05 
DMU8 4.48 3.00 1.05 167.7 3.41 -46 78 0.06 
DMU9 4.91 2.58 0.65 227.3 25.8 4.37 117 0.06 
DMU10 7.33 2.11 1.25 144.3 28.5 4.35 116 0.06 
Source: Annual Reports of the Respective Companies. 
 
After preparing decision matrix is generally followed by the weighting of the matrix by the weight 
vector. The weighting of the matrix is important because a weight implies relative priorities given by 
the researcher to different criteria’s. The weighted value of each criteria, sub-criteria and the resulting 
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weights obtained on the basis of entropy method are shown in Table 2. The procedure for obtaining 
weights of each criteria presented in Table 10 to 12. The magnitude of the weight value reflects the 
importance of the criterion. It is observed from Table 2 that Earnings Per Share (EPS) and Interest 
Cover(IC) have the highest- weighted values. The reason for this is that in some parts of the companies 
in the analysis such as Aurobindo Pharma Limited, Cipla Limited, Dr.Reddy’s Laboratories Limited, 
Lupin Limited and Ranbaxy Laboratories Limited takes excessively high values. According to the 
entopy method, inventory turnover and total assets turnover is at the lowest importance level. 
The next step in MCDM method is normalization of decision matrix in order to eliminate the scale 
effect. There are large numbers of normalization techniques that are followed by the different 
researchers in MCDM literature. In this study, linear scale normalization-sum method is used for 
normalization and presented in Table 4. 
 
Table 4. Normalized Decision Matrix (SAW Method) 
Companies OP NP ROC RON CR QR DER IC IT 
DMU1 0.52 0.36 0.31 0.45 0.40 0.74 0.11 0.01 0.62 
DMU2 0.47 0.61 0.43 0.67 0.39 0.35 0.21 0.01 0.84 
DMU3 0.68 0.67 0.51 0.61 0.74 0.45 1.00 0.08 0.50 
DMU4 0.73 0.69 0.39 0.40 0.79 0.73 0.80 0.19 0.88 
DMU5 1.00 0.92 1.00 1.00 0.67 0.44 0.39 0.00 1.00 
DMU6 0.70 0.64 0.36 0.56 0.64 1.00 0.14 0.01 0.99 
DMU7 0.63 0.56 0.52 0.80 0.41 0.50 0.16 0.03 0.78 
DMU8 0.36 0.11 0.28 -.05 0.38 0.30 0.09 0.02 0.62 
DMU9 0.49 1.00 0.48 0.58 1.00 0.77 0.38 1.00 0.78 
DMU10 0.66 0.58 0.54 0.72 0.51 0.33 0.29 0.03 0.73 
 
Companies RT FT TAT CCC EPS PE BV DY 
DMU1 0.11 0.22 0.62 0.52 0.60 0.07 0.54 0.06 
DMU2 0.26 0.18 0.77 0.65 0.46 0.14 0.33 0.28 
DMU3 0.17 0.25 0.78 0.41 0.39 0.15 0.30 0.22 
DMU4 0.14 0.25 0.55 0.58 0.95 0.26 1.00 0.11 
DMU5 1.00 1.00 1.00 1.00 1.00 1.00 0.53 1.00 
DMU6 0.12 0.32 0.55 0.45 0.19 0.18 0.18 0.11 
DMU7 0.16 0.22 0.84 0.59 0.68 0.12 0.41 0.28 
DMU8 0.17 0.28 0.76 0.57 0.06 -1.4 0.24 0.33 
DMU9 0.19 0.24 0.47 0.42 0.48 0.13 0.36 0.33 
DMU10 0.28 0.19 0.90 0.66 0.53 0.13 0.36 0.33 
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Source: Computed. 
 
After determining weights of the criteria and normalized decision matrix, then weightening of the 
normalized data matrix is done by multiplying normalized data matrix with the weight vector and 
presented in Table 5. The relative importance of the each alternatives based on SAW method according 
to the formula (3) and presented in Table 5. The ranking of the alternatives are given as per the value of 
relative importance given in the Table 5. From the table it can be seen that the three best 
pharmaceutical companies on the basis of SAW method are Glaxo Smith Kline Pharma Limited, Sun 
Pharmaceutical Industries Limited and Dr.Reddy’s Laboratories Limited. It is also understood from the 
Table 5 that the least performer belongs to Ranbaxy Laboratories Limited during the study period. 
 
Table 5. Weighted Normalized Decision Matrix (SAW Method) 
Companies OP NP ROC RON CR QR DER IC IT 
Weights 0.007 0.018 0.014 0.027 0.011 0.015 0.046 0.263 0.004 
DMU1 0.004 0.006 0.004 0.012 0.004 0.011 0.005 0.003 0.002 
DMU2 0.003 0.011 0.006 0.018 0.004 0.005 0.010 0.003 0.003 
DMU3 0.005 0.012 0.007 0.017 0.008 0.007 0.046 0.021 0.002 
DMU4 0.005 0.012 0.006 0.011 0.009 0.011 0.037 0.049 0.004 
DMU5 0.007 0.017 0.014 0.027 0.007 0.007 0.018 0.000 0.004 
DMU6 0.005 0.012 0.005 0.015 0.007 0.015 0.006 0.002 0.004 
DMU7 0.004 0.010 0.007 0.021 0.005 0.008 0.007 0.008 0.003 
DMU8 0.003 0.002 0.004 -.001 0.004 0.005 0.004 0.005 0.002 
DMU9 0.003 0.018 0.007 0.016 0.011 0.012 0.017 0.263 0.003 
DMU10 0.005 0.010 0.008 0.019 0.006 0.005 0.013 0.008 0.003 
 
Companies RT FT TAT CCC EPS PE BV DY PI Rank 
Weights 0.063 0.039 0.005 0.006 0.369 0.034 0.023 0.055   
DMU1 0.007 0.009 0.003 0.003 0.220 0.002 0.012 0.003 0.312 7 
DMU2 0.016 0.007 0.004 0.004 0.168 0.005 0.008 0.015 0.291 8 
DMU3 0.011 0.010 0.004 0.002 0.143 0.005 0.007 0.012 0.319 6 
DMU4 0.009 0.010 0.003 0.003 0.352 0.009 0.023 0.006 0.557 3 
DMU5 0.063 0.039 0.005 0.006 0.369 0.034 0.012 0.055 0.684 1 
DMU6 0.008 0.013 0.003 0.003 0.071 0.006 0.004 0.006 0.185 9 
DMU7 0.010 0.008 0.004 0.004 0.250 0.004 0.009 0.015 0.378 4 
DMU8 0.011 0.011 0.004 0.003 0.024 -.047 0.006 0.018 0.057 10 
DMU9 0.012 0.009 0.002 0.003 0.179 0.004 0.008 0.018 0.585 2 
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DMU10 0.017 0.008 0.004 0.004 0.197 0.004 0.008 0.018 0.339 5 
Source: Computed.  
 
3.2 ARAS Method 
First of all, the decision matrix related to the Indian pharmaceutical companies is along with the 
optimal alternative such as maximum value in case of benefit criteria and minimum value in case of 
cost criteria has been identified and presented in the Table 6. 
 
Table 6. Initial Decision Matrix (ARAS Method) 
Companies OP NP ROC RON CR QR DER IC IT 
DMU0 33.3 25.5 45.2 33.7 2.94 3.43 0.12 924.1 6.99 
DMU1 17.4 9.08 13.9 15.1 1.19 2.53 1.14 9.43 4.35 
DMU2 15.5 15.5 19.5 22.7 1.14 1.2 0.56 10.9 5.87 
DMU3 22.7 17.1 23.2 20.6 2.17 1.56 0.12 74.9 3.49 
DMU4 24.2 17.5 17.8 13.4 2.33 2.49 0.15 172.1 6.13 
DMU5 33.3 23.5 45.2 33.7 1.97 1.5 0.31 0 6.99 
DMU6 23.2 16.3 16.1 18.9 1.88 3.43 0.86 6.57 6.91 
DMU7 21.1 14.2 23.5 26.8 1.22 1.73 0.77 27.8 5.48 
DMU8 12.1 2.81 12.5 -1.6 1.12 1.04 1.4 18.9 4.31 
DMU9 16.3 25.5 21.8 19.5 2.94 2.63 0.32 924.1 5.46 
DMU10 21.9 14.7 24.6 24.1 1.51 1.13 0.41 27.6 5.13 
 
Companies RT FT TAT CCC EPS PE BV DY 
DMU0 26.4 10.9 1.39 95.3 53.3 33.5 325 0.18 
DMU1 3 2.38 0.86 184.7 31.8 2.24 175 0.01 
DMU2 6.76 1.91 1.07 145.7 24.3 4.69 106 0.05 
DMU3 4.4 2.7 1.08 231.4 20.7 5.16 98 0.04 
DMU4 3.7 2.73 0.77 164.8 50.8 8.67 325 0.02 
DMU5 26.4 10.9 1.39 95.3 53.3 33.5 173 0.18 
DMU6 3.27 3.53 0.76 212.9 10.3 6.19 60 0.02 
DMU7 4.27 2.37 1.17 161.7 36.1 3.92 132 0.05 
DMU8 4.48 3 1.05 167.7 3.41 -46 78 0.06 
DMU9 4.91 2.58 0.65 227.3 25.8 4.37 117 0.06 
DMU10 7.33 2.11 1.25 144.3 28.5 4.35 116 0.06 
Source: Annual Reports of the Respective Companies. 
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The next step in ARAS method is normalization of decision matrix in order to eliminate the scale effect 
by using  linear scale normalization-sum method and presented in Table 7. 
 
Table 7. Normalized Decision Matrix (ARAS Method) 
Companies OP NP ROC RON CR QR DER IC IT 
DMU0 0.14 0.14 0.17 0.15 0.14 0.15 0.22 0.42 0.11 
DMU1 0.07 0.05 0.05 0.07 0.06 0.11 0.02 0.00 0.07 
DMU2 0.06 0.09 0.07 0.10 0.06 0.05 0.05 0.00 0.10 
DMU3 0.09 0.09 0.09 0.09 0.11 0.07 0.22 0.03 0.06 
DMU4 0.10 0.10 0.07 0.06 0.11 0.11 0.18 0.08 0.10 
DMU5 0.14 0.13 0.17 0.15 0.10 0.07 0.08 0.00 0.11 
DMU6 0.10 0.09 0.06 0.08 0.09 0.15 0.03 0.00 0.11 
DMU7 0.09 0.08 0.09 0.12 0.06 0.08 0.03 0.01 0.09 
DMU8 0.05 0.02 0.05 -.01 0.05 0.05 0.02 0.01 0.07 
DMU9 0.07 0.14 0.08 0.09 0.14 0.12 0.08 0.42 0.09 
DMU10 0.09 0.08 0.09 0.11 0.07 0.05 0.06 0.01 0.08 
 
Companies RT FT TAT CCC EPS PE BV DY 
DMU0 0.28 0.24 0.12 0.15 0.16 0.55 0.19 0.25 
DMU1 0.03 0.05 0.08 0.08 0.09 0.04 0.10 0.01 
DMU2 0.07 0.04 0.09 0.10 0.07 0.08 0.06 0.07 
DMU3 0.05 0.06 0.09 0.06 0.06 0.09 0.06 0.05 
DMU4 0.04 0.06 0.07 0.08 0.15 0.14 0.19 0.03 
DMU5 0.28 0.24 0.12 0.15 0.16 0.55 0.10 0.25 
DMU6 0.03 0.08 0.07 0.07 0.03 0.10 0.04 0.03 
DMU7 0.04 0.05 0.10 0.09 0.11 0.06 0.08 0.07 
DMU8 0.05 0.07 0.09 0.08 0.01 -.76 0.05 0.08 
DMU9 0.05 0.06 0.06 0.06 0.08 0.07 0.07 0.08 
DMU10 0.08 0.05 0.11 0.10 0.08 0.07 0.07 0.08 
Sources: Computed. 
 
After determining weights of the criteria and normalized decision matrix, then weightening of the 
normalized data matrix is done by multiplying normalized data matrix with the weight vector and 
presented in Table 8. 
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Table 8. Weighted Normalized Decision Matrix (ARAS Method) 
Companies OP NP ROC RON CR QR DER IC IT 
Weights 0.007 0.018 0.014 0.027 0.011 0.015 0.046 0.263 0.004 
DMU0 0.001 0.003 0.002 0.004 0.002 0.002 0.010 0.111 0.000 
DMU1 0.001 0.001 0.001 0.002 0.001 0.002 0.001 0.001 0.000 
DMU2 0.000 0.002 0.001 0.003 0.001 0.001 0.002 0.001 0.000 
DMU3 0.001 0.002 0.001 0.002 0.001 0.001 0.010 0.009 0.000 
DMU4 0.001 0.002 0.001 0.002 0.001 0.002 0.008 0.021 0.000 
DMU5 0.001 0.002 0.002 0.004 0.001 0.001 0.004 0.000 0.000 
DMU6 0.001 0.002 0.001 0.002 0.001 0.002 0.001 0.001 0.000 
DMU7 0.001 0.001 0.001 0.003 0.001 0.001 0.002 0.003 0.000 
DMU8 0.000 0.000 0.001 0.000 0.001 0.001 0.001 0.002 0.000 
DMU9 0.000 0.003 0.001 0.002 0.002 0.002 0.004 0.111 0.000 
DMU10 0.001 0.001 0.001 0.003 0.001 0.001 0.003 0.003 0.000 
 
Companies RT FT TAT CCC EPS PE BV DY Si 
Weights 0.063 0.039 0.005 0.006 0.369 0.034 0.023 0.055 1.000 
DMU0 0.018 0.009 0.001 0.001 0.058 0.019 0.004 0.014 0.258 
DMU1 0.002 0.002 0.000 0.000 0.035 0.001 0.002 0.001 0.053 
DMU2 0.004 0.002 0.000 0.001 0.027 0.003 0.001 0.004 0.052 
DMU3 0.003 0.002 0.000 0.000 0.023 0.003 0.001 0.003 0.063 
DMU4 0.002 0.002 0.000 0.001 0.055 0.005 0.004 0.002 0.109 
DMU5 0.018 0.009 0.001 0.001 0.058 0.019 0.002 0.014 0.137 
DMU6 0.002 0.003 0.000 0.000 0.011 0.003 0.001 0.002 0.034 
DMU7 0.003 0.002 0.001 0.001 0.039 0.002 0.002 0.004 0.067 
DMU8 0.003 0.003 0.000 0.000 0.004 -0.026 0.001 0.005 -0.004 
DMU9 0.003 0.002 0.000 0.000 0.028 0.002 0.002 0.005 0.167 
DMU10 0.005 0.002 0.001 0.001 0.031 0.002 0.002 0.005 0.062 
Source: Computed. 
 
The overall performance index Si for each alternative can be calculated as the sum of the weighted 
normalized performance ratings as prescribed in the equation (4) is calculated and presented in Table 9. 
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Table. 9 The Overall Performance Indexes and Degree of Utility (ARAS Method) 
 Si Qi Rank 
DMU0 0.258   
DMU1 0.053 0.204 7 
DMU2 0.052 0.203 8 
DMU3 0.063 0.246 5 
DMU4 0.109 0.421 3 
DMU5 0.137 0.532 2 
DMU6 0.034 0.133 9 
DMU7 0.067 0.258 4 
DMU8 -0.004 -0.016 10 
DMU9 0.167 0.648 1 
DMU10 0.062 0.239 6 
Source: Computed. 
 
While evaluating alternatives, it is not only important that the best ranked alternative should be 
determined, but also that the relative performances of the considered alternatives should be determined 
in relation to the best ranked alternative. For this purpose, it is needed to compute the degree of utility 
(Qi) of each alternative based on ARAS method according to the formula (5) and presented in Table 9. 
The considered alternatives are ranked by ascending Qi, i.e., the alternatives with the higher values of 
Qi, have a higher priority (rank) and the alternative with the largest value of Qi, is the best placed. The 
ranking of the alternatives are given as per the value of relative importance in the Table 9.  From the 
table it can be seen that the three best pharmaceutical companies on the basis of ARAS method are Sun 
Pharmaceutical Industries Ltd, Glaxo Smith Kline Pharma Limited and Dr.Reddy’s Laboratories 
Limited. It is also understood from the Table 9 that the least performer belongs to Ranbaxy 
Laboratories Limited during the study period. 
 
4. Discussion 
4.1 SAW and ARAS Methods—A Comparison 
The comparison of results of SAW and ARAS methods are presented in Table 10. 
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Table 10. Rankings of SAW and ARAS Method—A Comparison 
Number of Decision 
Making Units 
(DMU) 
Name of the Pharmaceutical Company Rank by 
SAW       
    Method  
Rank by 
ARAS     
     Method 
DMU-1 Aurobindo Pharma Limited 7 7 
DMU2 Cadila Pharmaceutical Limited 8 8 
DMU3 Cipla Ltd 6 5 
DMU4 Dr. Reddy’s Laboratories Ltd 3 3 
DMU5 Glaxo Smith Kline Pharma Ltd 1 2 
DMU6 Glenmark Pharmaceuticals Limited 9 9 
DMU7 Lupin Ltd 4 4 
DMU8 Ranbaxy Laboratories Limited 10 10 
DMU9 Sun Pharmaceutical Industries Ltd 2 1 
DMU10 Torrent Pharmaceuticals Limited 5 6 
Source: Computed. 
 
It is inferred from the Table 10 that both MCDM methods, SAW and ARAS, revealed same rankings of 
companies in Indian pharmaceutical industry during the study period except two changes. According to 
SAW method the first rank is given to Glaxo Smith Kline Pharma Limited whereas in ARAS method, 
the first rank given to Sun Pharmaceutical Industries Ltd and the Cipla Limited given 6th rank in SAW 
method, but in ARAS method, it is given 5th rank according to their performance. Except the above 
changes, all other companies are obtained similar rankings according to SAW and ARAS method 
during the study period. 
 
5. Conclusion 
The study analysed 2006-2019 financial performances of ten selected Indian pharmaceutical companies 
and employed two simplest MCDM methods such as Simple Additive Weighting (SAW) method and 
Additive Ratio Assessment (ARAS) as its method of analysis. The results of the study shows that the 
best performance belongs to Glaxo Smith Kline Pharma Limited in SAW method and Sun 
Pharmaceutical Industries Ltd in ARAS method and worst performance belongs to Ranbaxy 
Laboratories Limited in both methods. By comparison, both methods revealed the similar rankings of 
companies during the study period. The applicability of the SAW and ARAS methods with the use of 
the entropy weightings to the problem of Indian pharmaceutical company’s financial performance 
evaluation suggests that it is feasible for different sectors. As the scope of this study was only 
pharmaceutical industry, the large number of industry, financial ratios and period intervals and the 
wideness of the data set can be considered as a valuable resource for further research. 
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Note 
Note 1. The process of determining the weighted value for the criteria by the entropy method is as 
follows: 
 
Table 11. Normalized Decision Matrix for Weight Determination under Entropy Method 
Companies OP NP ROC RON CR QR DER IC IT 
DMU1 0.08 0.06 0.06 0.08 0.07 0.13 0.19 0.01 0.08 
DMU2 0.07 0.10 0.09 0.12 0.07 0.06 0.09 0.01 0.11 
DMU3 0.11 0.11 0.11 0.11 0.12 0.08 0.02 0.06 0.06 
DMU4 0.12 0.11 0.08 0.07 0.13 0.13 0.02 0.14 0.11 
DMU5 0.16 0.15 0.21 0.17 0.11 0.08 0.05 0.00 0.13 
DMU6 0.11 0.10 0.07 0.10 0.11 0.18 0.14 0.01 0.13 
DMU7 0.10 0.09 0.11 0.14 0.07 0.09 0.13 0.02 0.10 
DMU8 0.06 0.02 0.06 -0.01 0.06 0.05 0.23 0.01 0.08 
DMU9 0.08 0.16 0.10 0.10 0.17 0.14 0.05 0.73 0.10 
DMU10 0.11 0.09 0.11 0.12 0.09 0.06 0.07 0.02 0.09 
 
Companies RT FT TAT CCC EPS PE BV DY 
DMU1 0.04 0.07 0.09 0.11 0.11 0.08 0.13 0.02 
DMU2 0.10 0.06 0.11 0.08 0.09 0.17 0.08 0.09 
DMU3 0.06 0.08 0.11 0.13 0.07 0.19 0.07 0.07 
DMU4 0.05 0.08 0.08 0.09 0.18 0.32 0.24 0.04 
DMU5 0.39 0.32 0.14 0.05 0.19 1.24 0.13 0.33 
DMU6 0.05 0.10 0.08 0.12 0.04 0.23 0.04 0.04 
DMU7 0.06 0.07 0.12 0.09 0.13 0.14 0.10 0.09 
DMU8 0.07 0.09 0.10 0.10 0.01 -1.70 0.06 0.11 
DMU9 0.07 0.08 0.06 0.13 0.09 0.16 0.08 0.11 
DMU10 0.11 0.06 0.12 0.08 0.10 0.16 0.08 0.11 
 
Table 12. Value of Entropy 
 
Value of 
Entropy 
  ln(10) 2.3026 
  h=1/ln(10) 0.4343 (-h)= -0.4343 
Source: Computed. 
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Table 13. Determination of Weights 
Companies OP NP ROC RON CR QR DER IC IT 
DMU1 -0.21 -0.17 -0.18 -0.20 -0.18 -0.27 -0.31 -0.04 -0.20 
DMU2 -0.19 -0.23 -0.22 -0.25 -0.18 -0.17 -0.22 -0.04 -0.24 
DMU3 -0.24 -0.24 -0.24 -0.24 -0.26 -0.20 -0.08 -0.17 -0.18 
DMU4 -0.25 -0.25 -0.20 -0.19 -0.27 -0.26 -0.09 -0.27 -0.25 
DMU5 -0.29 -0.28 -0.33 -0.30 -0.25 -0.20 -0.15 0.00 -0.26 
DMU6 -0.24 -0.24 -0.19 -0.23 -0.24 -0.31 -0.28 -0.03 -0.26 
DMU7 -0.23 -0.22 -0.24 -0.27 -0.19 -0.22 -0.26 -0.08 -0.23 
DMU8 -0.17 -0.07 -0.16 0.00 -0.18 -0.16 -0.34 -0.06 -0.20 
DMU9 -0.20 -0.30 -0.23 -0.23 -0.30 -0.27 -0.16 -0.23 -0.23 
DMU10 -0.24 -0.22 -0.25 -0.26 -0.21 -0.17 -0.18 -0.08 -0.22 
Sum -2.27 -2.21 -2.23 -2.17 -2.25 -2.23 -2.07 -1.00 -2.28 
ej=(-h*Sum) 0.98 0.96 0.97 0.94 0.98 0.97 0.90 0.44 0.99 
d=(1-ej) 0.02 0.04 0.03 0.06 0.02 0.03 0.10 0.56 0.01 
Weights 0.007 0.018 0.014 0.027 0.011 0.015 0.046 0.263 0.004 
 
Companies RT FT TAT CCC EPS PE BV DY 
DMU1 -0.14 -0.19 -0.21 -0.24 -0.05 -0.21 -0.26 -0.07 
DMU2 -0.23 -0.16 -0.24 -0.21 -0.03 -0.30 -0.20 -0.22 
DMU3 -0.18 -0.20 -0.24 -0.27 -0.03 -0.32 -0.19 -0.19 
DMU4 -0.16 -0.20 -0.20 -0.22 -0.10 -0.36 -0.34 -0.12 
DMU5 -0.37 -0.36 -0.27 -0.16 -0.11 0.26 -0.26 -0.37 
DMU6 -0.15 -0.23 -0.20 -0.26 -0.01 -0.34 -0.14 -0.12 
DMU7 -0.17 -0.18 -0.25 -0.22 -0.06 -0.28 -0.22 -0.22 
DMU8 -0.18 -0.21 -0.24 -0.23 0.00 0.00 -0.16 -0.24 
DMU9 -0.19 -0.19 -0.18 -0.27 -0.04 -0.29 -0.21 -0.24 
DMU10 -0.24 -0.17 -0.26 -0.21 -0.04 -0.29 -0.21 -0.24 
Sum -1.99 -2.11 -2.28 -2.28 -0.48 -2.13 -2.19 -2.03 
ej=(-h*Sum) 0.86 0.92 0.99 0.99 0.21 0.93 0.95 0.88 
d=(1-ej) 0.14 0.08 0.01 0.01 0.79 0.07 0.05 0.12 
Weights 0.063 0.039 0.005 0.006 0.369 0.034 0.023 0.055 
Source: Computed. 
